CorMedix Competitors and Similar CompaniesClear all
CorMedix's competitors and similar companies include Veloxis Pharmaceuticals and Oncologie.
 CorMedix CorMedix is a pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the treatment of cardiac and kidney disease. |  Veloxis Pharmaceuticals Veloxis Pharmaceuticals is a biopharmaceutical company that identifies, develops, and commercializes products used in transplantation and adjacent therapies. | ||
Founding Date | Founding Date 2006 | Founding Date 2002 | Founding Date 2018 |
Type | Type Public | Type Subsidiary | Type Private |
Tags | |||
Locations | Locations Berkeley Heights, US HQ | Locations København, DK HQ Cary, US Cary, US | Locations Waltham, US HQ Shanghai, CN Boston, US |
Employees | Employees 3036% increase | Employees 54 | Employees 8 |
Financial | |||
Revenue (est.) | Revenue (est.) $311.7m (FY, 2025) | Revenue (est.) kr39.5m (FY, 2018) | Revenue (est.) N/A |
Cost of goods | Cost of goods $22.1m (FY, 2025) | Cost of goods kr7.9m (FY, 2018) | Cost of goods N/A |
Gross profit | Gross profit $275.7m (FY, 2025) | Gross profit kr31.6m (FY, 2018) | Gross profit N/A |
Net income | Net income $163.1m (FY, 2025) | Net income (kr5.3m) (FY, 2018) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 11.5m | Total funding raised $ 60m | Total funding raised $ 96.5m |
For sources of this data, please see the company profile
View Company Profiles
Veloxis Pharmaceuticals
HQ
København, DK
Veloxis Pharmaceuticals is a biopharmaceutical company that identifies, develops, and commercializes products used in transplantation and adjacent therapies.
View company